Submit your claim details for a free, no obligation case review
Get Started:
Vioxx was approved in Canada in 1999, quickly becoming the country''s 10 th top selling drug. In 2003, more than 3.36 million prescriptions of Vioxx were filled, costing $194.4 million. After Merck announced Vioxx was being pulled off the market, two class action lawsuits were been filed on behalf of Canadians who used the popular arthritis drug prior to the recall announcement.
One class action lawsuit was filed in Saskatchewan against Merck Frosst Canada LTD., Merck & Co. Inc. and the Queen as represented by the Minister of Health and Welfare Canada and the Attorney-General of Canada. The second class action lawsuit was filed in North Vancouver, B.C., against Merck Frosst Canada Ltd. and associated firms, developers and promoters of Vioxx.